Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

[CONs].

Sobue T.

Gan To Kagaku Ryoho. 2014 May;41(5):553-7. Japanese.

PMID:
24917002
2.

Prostate-specific antigen screening for prostate cancer in older men in the United States of America.

Black A, Berg CD.

Gerontology. 2012;58(4):331-6. doi: 10.1159/000334242. Epub 2012 Feb 16.

PMID:
22343605
3.

Screening for prostate cancer: a guidance statement from the Clinical Guidelines Committee of the American College of Physicians.

Qaseem A, Barry MJ, Denberg TD, Owens DK, Shekelle P; Clinical Guidelines Committee of the American College of Physicians.

Ann Intern Med. 2013 May 21;158(10):761-9. doi: 10.7326/0003-4819-158-10-201305210-00633.

PMID:
23567643
4.

Screening for prostate cancer: the current evidence and guidelines controversy.

Gomella LG, Liu XS, Trabulsi EJ, Kelly WK, Myers R, Showalter T, Dicker A, Wender R.

Can J Urol. 2011 Oct;18(5):5875-83. Review.

5.

Prostate Cancer Screening and the Associated Controversy.

Tabayoyong W, Abouassaly R.

Surg Clin North Am. 2015 Oct;95(5):1023-39. doi: 10.1016/j.suc.2015.05.001. Epub 2015 Jun 23. Review.

PMID:
26315521
6.

[Focus on the screening for prostate cancer by PSA].

Roumeguère T, Van Velthoven R.

Rev Med Brux. 2013 Sep;34(4):311-9. Review. French.

PMID:
24195246
7.

Response to the U.S. Preventative Services Task Force decision on prostate cancer screening.

Makovey I, Stephenson AJ, Haywood S.

Curr Urol Rep. 2013 Jun;14(3):168-73. doi: 10.1007/s11934-013-0318-9.

PMID:
23568623
8.

The impact of recent screening recommendations on prostate cancer screening in a large health care system.

Aslani A, Minnillo BJ, Johnson B, Cherullo EE, Ponsky LE, Abouassaly R.

J Urol. 2014 Jun;191(6):1737-42. doi: 10.1016/j.juro.2013.12.010. Epub 2013 Dec 14.

PMID:
24342148
9.

Comment on the US Preventive Services Task Force's draft recommendation on screening for prostate cancer.

Kwiatkowski M, Klotz L, Hugosson J, Recker F.

Eur Urol. 2012 Apr;61(4):851-4. doi: 10.1016/j.eururo.2012.01.023. Epub 2012 Jan 24. No abstract available.

PMID:
22285762
10.

American Urological Association (AUA) guideline on prostate cancer detection: process and rationale.

Carter HB.

BJU Int. 2013 Sep;112(5):543-7. doi: 10.1111/bju.12318. Review.

11.

Risks of PSA screening now better understood.

Peres J.

J Natl Cancer Inst. 2013 Nov 6;105(21):1590-2. doi: 10.1093/jnci/djt328. Epub 2013 Oct 18. No abstract available.

12.

2008 US Preventive Services Task Force recommendations and prostate cancer screening rates.

Prasad SM, Drazer MW, Huo D, Hu JC, Eggener SE.

JAMA. 2012 Apr 25;307(16):1692-4. doi: 10.1001/jama.2012.534. No abstract available.

PMID:
22535850
13.

PSA screening: the USPSTF got it wrong.

Scherger JE.

J Fam Pract. 2013 Nov;62(11):616, 618. No abstract available.

14.

Risk stratification in prostate cancer screening.

Roobol MJ, Carlsson SV.

Nat Rev Urol. 2013 Jan;10(1):38-48. doi: 10.1038/nrurol.2012.225. Epub 2012 Dec 18. Review. Erratum in: Nat Rev Urol. 2013 May;10(5):248.

PMID:
23247693
15.

Updated Japanese Urological Association Guidelines on prostate-specific antigen-based screening for prostate cancer in 2010.

Committee for Establishment of the Guidelines on Screening for Prostate Cancer; Japanese Urological Association.

Int J Urol. 2010 Oct;17(10):830-8. doi: 10.1111/j.1442-2042.2010.02613.x.

16.

Preventive Services Task Force recommends against PSA screening after age 75.

Twombly R.

J Natl Cancer Inst. 2008 Nov 19;100(22):1571-3. doi: 10.1093/jnci/djn422. Epub 2008 Nov 11. No abstract available.

17.

Five-year downstream outcomes following prostate-specific antigen screening in older men.

Walter LC, Fung KZ, Kirby KA, Shi Y, Espaldon R, O'Brien S, Freedland SJ, Powell AA, Hoffman RM.

JAMA Intern Med. 2013 May 27;173(10):866-73. doi: 10.1001/jamainternmed.2013.323.

18.

National evidence on the use of shared decision making in prostate-specific antigen screening.

Han PK, Kobrin S, Breen N, Joseph DA, Li J, Frosch DL, Klabunde CN.

Ann Fam Med. 2013 Jul-Aug;11(4):306-14. doi: 10.1370/afm.1539.

19.

Prostate cancer screening in men 75 years old or older: an assessment of self-reported health status and life expectancy.

Hoffman KE, Nguyen PL, Ng AK, D'Amico AV.

J Urol. 2010 May;183(5):1798-802. doi: 10.1016/j.juro.2010.01.002. Epub 2010 Mar 17.

PMID:
20299039
20.

Detection of prostate cancer: the impact of the European Randomized Study of Screening for Prostate Cancer (ERSPC).

Schröder FH.

Can J Urol. 2005 Feb;12 Suppl 1:2-6; discussion 92-3. Review.

PMID:
15780157
Items per page

Supplemental Content

Write to the Help Desk